%0 Journal Article %A Achunair, Abhishek %A Patel, Vivek %D 2020 %I Begell House %K artificial intelligence, musculoskeletal disorders %N 1 %P 59-73 %R 10.1615/CritRevPhysRehabilMed.2020033776 %T The Role of Artificial Intelligence in Treating Musculoskeletal Disorders %U https://www.dl.begellhouse.com/journals/757fcb0219d89390,2f0c9db549df3851,153c437533e9d46d.html %V 32 %X Musculoskeletal disorders (MSDs) are a group of conditions affecting the locomotor system; the symptoms can range from fractures or sprains to ongoing pain and disability. According to the World Health Organization, MSD conditions are a leading cause of disability worldwide. In the United States alone, 1 in every 2 adults live with a musculoskeletal condition. The most common of these conditions include osteoarthritis, back and neck pain, as well as inflammatory conditions such as rheumatoid arthritis. The prevalence of these conditions results in a limitation on daily functioning of both children and working adults. In 2011, musculoskeletal conditions cost approximately US$213 billion in healthcare costs, accompanied by an overall reduction in workplace productivity. In addition, a recent study reported that MSDs were the highest contributor to global disability in 2017. To manage the rising levels of musculoskeletal conditions, artificial intelligence (AI) is being increasingly used in healthcare settings and has shown potential in prognosing and determining the severity of several MSDs. The following review paper will examine AI modalities present in diagnosing and/or treating MSDs and future implications in helping treat those individuals with these conditions. Artificial intelligence has been used in the healthcare through surgical and imaging interventions, in addition to helping diagnose and better treat, one of the most prevalent MSDs, arthritis. %8 2020-04-21